Revision of Melinta Therapeutics

{{DISPLAYTITLE:Melinta Therapeutics}}
Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings.<small> from [https://en.wikipedia.org/wiki/Melinta_Therapeutics Wikipedia]</small>
{|
|+ 
|-
! Icon !! Service !! Username !!
|-
| [[File:TwitterGrey.svg|30px|link=|frameless|center]] || Twitter || [https://www.twitter.com/melintatx @melintatx] || [[File:OOjs UI icon check-progressive.svg|30px|link=|frameless|center]]
|-
| [[File:WebsiteGrey.png|29px|link=|frameless|center]] || Website || [http://www.rib-x.com rib-x.com] || [[File:OOjs UI icon check-progressive.svg|30px|link=|frameless|center]]
{{Twt|melintatx}}
{{Wb|http://www.rib-x.com|rib-x.com}}
|}

[[VHID]]:[https://verifiedhandles.com/vhid/22131679024 22131679024]
{{#subtitle: <big>American pharmaceutical company</big>}}